Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bellerophon Therapeutics Inc
BLPHCurrent price
0.051 USD
0 USD (0.00%)
Last closed
0.051 USD
Company
bellerophon.com
Sector
Healthcare
Industry
Biotechnology
Exchange
PINK
Capitalization
623 862 USD
Yield for 12 month
-88.81 %
1Y
3Y
5Y
10Y
15Y
BLPH
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse, which is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey. Address: 20 Independence Boulevard, Warren, NJ, United States, 07059
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 USDP/E ratio
–Dividend Yield
–Current Year
+5 640 000 USD
Last Year
+5 640 000 USD
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures BLPH
1 year
3 years
5 years
10 years
EBITDA
-11 035 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-78.47 %
PEG Ratio
–
Return On Equity TTM
-165.96 %
Wall Street Target Price
2 USD
Revenue TTM
5 640 000 USD
Book Value
0.3 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.89 USD
Diluted Eps TTM
-0.89 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
-164.06 %
Dividend Analytics BLPH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BLPH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
10.02.2020
Dividend Date
10.02.2020
Stock Valuation BLPH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
0.1193
Enterprise Value EBITDA
1.3138
Price Book MRQ
0.1807
Financials BLPH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BLPH
For 52 weeks
0.029 USD
0.72 USD
50 Day MA
0.057 USD
Shares Short Prior Month
197 473
200 Day MA
0.053 USD
Short Ratio
1.26
Shares Short
90 446
Short Percent
0.9 %
BeatStart